GTEx Colon 20-29 vs 70-79 Up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GTEx Colon 20-29 vs 70-79 Up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GTEx Colon 20-29 vs 70-79 Up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GTEx Colon 20-29 vs 70-79 Up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GTEx Colon 20-29 vs 70-79 Up.

Results found

Linked to

 

Label

Description

 

Gene

H19 imprinted maternally expressed transcript

Gene

double homeobox A pseudogene 8

Gene

p53 upregulated regulator of p53 levels

Gene

FOXD3 antisense RNA 1

Gene

WT1 antisense RNA

Gene

ZFHX4 antisense RNA 1

Gene

major histocompatibility complex, class I, V (pseudogene)

Gene

long intergenic non-protein coding RNA 1085

Gene

SOX2 overlapping transcript

Gene

prostate androgen-regulated transcript 1

  • Gene

    H19 imprinted maternally expressed transcript


  • Gene

    double homeobox A pseudogene 8


  • Gene

    p53 upregulated regulator of p53 levels


  • Gene

    FOXD3 antisense RNA 1


  • Gene

    WT1 antisense RNA


  • Gene

    ZFHX4 antisense RNA 1


  • Gene

    major histocompatibility complex, class I, V (pseudogene)


  • Gene

    long intergenic non-protein coding RNA 1085


  • Gene

    SOX2 overlapping transcript


  • Gene

    prostate androgen-regulated transcript 1

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.